Get started today with a consultation to explore if Qsymia or a GLP-1 alternative may be well-suited to your needs
Monitoring GLP-1 use among women newly diagnosed with PMOS helps characterize a rapidly evolving treatment landscape and how these therapies may coincide with changes in downstream treatment patterns
PlexusDx serves all 50 states with no geographic restrictions, ensuring consistent accessibility whether you're using tax-advantaged funds or paying directly
Clean Provider Records Minor issues Strive Compounding Pharmacy, one of LifeRxs named pharmacy partners, received formal disciplinary action from the Arizona Board of Pharmacy in February 2024 for improper semaglutide compounding and inaccurate compounding records, resulting in a $1,000 civil penalty
"I don't see employers being highly motivated to add what is probably going to be another high volume, very high cost drug to their formulary when the direct-to-consumer pricing for it is so much cheaper," Crable said